Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-014905
Filing Date
2011-03-15
Accepted
2011-03-15 16:20:25
Documents
12
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v214352_10k.htm 10-K 1815889
2 GRAPHIC footer.jpg GRAPHIC 16893
3 GRAPHIC logo.jpg GRAPHIC 19713
4 GRAPHIC pg7.jpg GRAPHIC 28369
5 GRAPHIC pg8.jpg GRAPHIC 35098
6 v214352_ex23-1.htm EX-23.1 5176
7 GRAPHIC bkr_logo.jpg GRAPHIC 7192
8 GRAPHIC yp_logo.jpg GRAPHIC 11252
9 v214352_ex31-1.htm EX-31.1 12275
10 v214352_ex31-2.htm EX-31.2 12159
11 v214352_ex32-1.htm EX-32.1 7074
12 v214352_ex32-2.htm EX-32.2 6784
  Complete submission text file 0001144204-11-014905.txt   2024659
Mailing Address 3 SAPIR STREET WEIZMANN SCIENCE PARK NES-ZIONA L3 74140
Business Address 3 SAPIR STREET WEIZMANN SCIENCE PARK NES-ZIONA L3 74140 (866) 644-7811
PROLOR Biotech, Inc. (Filer) CIK: 0001268659 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34676 | Film No.: 11688790
SIC: 2834 Pharmaceutical Preparations